Skip to main content

Tag: Inmates

Opioid Settlement Fuels The Psychiatric Industry, Right Back to Big Pharma

March 19, 2025

The Opioid Settlement Big Money, Big Business No Drug Safety Funded

In a shocking deep dive, billions of dollars from opioid settlements appear to be strategically redirected back into the pockets of pharmaceutical giants and the behavioral health – psychiatric industry. The settlements, now totaling a staggering $56.9 billion, were meant to address the devastating opioid crisis, but there’s a disturbing lack of oversight on how this money is spent.

At least 70% of the settlement funds must go towards “opioid remediation efforts,” including expanding access to addiction treatments. Here’s the kicker, many of these treatments are psychiatric medications produced by the very same pharmaceutical companies involved in the opioid crisis and will be used on the prison population and mental health courts, which fuels the psychiatric drug and behavioral health industry.  Many psychiatric drugs carry blackbox suicide warnings and other deadly side effects.  The psychiatric and behavioral health industry must label you in order to qualify for these dangerous unproven solutions. A win/win for the both mega industries.

Continue reading